The Japanese Ministry of Health, Labor and Welfare (MHLW) in Japan has approved Sarclisa (isatuximab), in combination with ...

South Korean firm Celltrion announced that the European Commission (EC) has granted marketing authorization for Avtozma ...

After a significant increase in 2023, Danish regions' expenses for subsidized medicines fell by 4.3% in 2024.

US pharma giant Pfizer has ended all development and commercialization activities relating to fidanacogene elaparvovec, a ...

US CNS-focused biopharma firm Axsome Therapeutics today announced that the EMERGE Phase III trial of Symbravo (MoSEIC ...

One of the USA’s largest compounders, Hims & Hers, has announced the acquisition of a peptide facility in California.

Mitsubishi Tanabe Pharma (MTPC) today announced that the European Medicines Agency (EMA) has accepted for review the ...

Spanish dermatology company Almirall was trading 4% higher on Monday afternoon after presenting its full-year 2024 financial ...

Swiss generics and biosimilars major Sandoz has announced the launch of Pyzchiva (ustekinumab-ttwe) in the USA. From today, ...